Clinical Trials Browser

Phase 2 × Uveal Melanoma × Interleukin-12 Subunit p35 × Clear all

NCT00003339 2014-05-22

Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma

NCT00031733 2014-05-22

Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma